Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study

被引:225
作者
Battaglia, J [1 ]
Moss, S [1 ]
Rush, J [1 ]
Kang, J [1 ]
Mendoza, R [1 ]
Leedom, L [1 ]
Dubin, W [1 ]
McGlynn, C [1 ]
Goodman, L [1 ]
机构
[1] ALASKA PSYCHIAT INST,ANCHORAGE,AK
关键词
haloperidol; lorazepam; psychotic agitation; rapid tranquilization;
D O I
10.1016/S0735-6757(97)90119-4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rapid tranquilization is a routinely practiced method of calming agitated psychotic patients by use of neuroleptics, benzodiazepines, or both in combination, Although several studies have examined the efficacy of the three approaches, none have compared these treatments in a prospective, randomized, double-blind, multicenter trial. Ninety eight psychotic, agitated, and aggressive patients (73 men and 25 women) were prospectively enrolled during an 18-month period in emergency departments in five university or general hospitals. Patients were randomly assigned to receive intramuscular injections of lorazepam (2 mg), haloperidol (5 mg), or both in combination, Patients in each treatment group received 1 to 6 injections of the same study drug within 12 hours, based on clinical need, They were evaluated hourly after the first injection until at least 12 hours after the last. Efficacy was assessed on the Agitated Behavior Scale (ABS), a modified Brief Psychiatric Rating Scale (MBPRS), Clinical Global Impressions (CGI) scale, and an Alertness Scale. Effective symptom reduction was achieved in each treatment group with significant (P < .01) mean decreases from baseline at every hourly ABS evaluation. Significant (P < .05) mean differences on the ABS (hour 1) and MBPRS (hours 2 and 3) suggest that tranquilization was most rapid in patients receiving the combination treatment, Study event incidence (side effects) did not differ significantly between treatment groups, although patients receiving haloperidol alone tended to have more extrapyramidal system symptoms, The superior results produced by the combination treatment support the use of lorazepam plus haloperidol as the treatment of choice for acute psychotic agitation. (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:335 / 340
页数:6
相关论文
共 50 条
  • [41] Comparison of Rapidly Acting Intramuscular Olanzapine, Lorazepam, and Placebo: A Double-blind, Randomized Study in Acutely Agitated Patients with Dementia
    Karena M Meehan
    Huei Wang
    Stacy R David
    Jennifer R Nisivoccia
    Barry Jones
    Charles M Beasley
    Peter D Feldman
    Jacobo E Mintzer
    Louise M Beckett
    Alan Breier
    [J]. Neuropsychopharmacology, 2002, 26 : 494 - 504
  • [42] Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: A double-blind, randomized study in acutely agitated patients with dementia
    Meehan, KM
    Wang, HE
    David, SR
    Nisivoccia, JR
    Jones, B
    Beasley, CM
    Feldman, PD
    Mintzer, JE
    Beckett, LM
    Breier, A
    [J]. NEUROPSYCHOPHARMACOLOGY, 2002, 26 (04) : 494 - 504
  • [43] Effect of Nicotine Replacement Therapy on Agitation in Smokers With Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Study
    Allen, Michael H.
    Debanne, Martin
    Lazignac, Coralie
    Adam, Eric
    Dickinson, L. Miriam
    Damsa, Cristian
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (04) : 395 - 399
  • [44] Reboxetine add on therapy to haloperidol in the treatment of schizophrenia: a preliminary double-blind randomized placebo-controlled study
    Schutz, G
    Berk, M
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (05) : 275 - 278
  • [45] Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia:: results of a multicentre, double-blind study (the Amisulpride Study Group)
    Carrière, P
    Bonhomme, D
    Lempérière, T
    [J]. EUROPEAN PSYCHIATRY, 2000, 15 (05) : 321 - 329
  • [46] PHENOBARBITAL FOR ACUTE ALCOHOL WITHDRAWAL: A PROSPECTIVE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    Rosenson, Jonathan
    Clements, Carter
    Simon, Barry
    Vieaux, Jules
    Graffman, Sarah
    Vahidnia, Farnaz
    Cisse, Bitou
    Lam, Joseph
    Alter, Harrison
    [J]. JOURNAL OF EMERGENCY MEDICINE, 2013, 44 (03) : 592 - +
  • [47] Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study
    Garcia-Gea, Consuelo
    Rosa Ballester, Maria
    Martinez, Juan
    Maria Antonijoan, Rosa
    Donado, Esther
    Izquierdo, Inaki
    Barbanoj, Manuel-Jose
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (06) : 663 - 674
  • [48] Double-blind crossover study of chlorpromazine and lorazepam in the treatment of behavioral problems during treatment of children with acute lymphoblastic leukaemia receiving glucocorticoids
    Pelletier, G
    Lacroix, Y
    Moghrabi, A
    Robaey, P
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 2000, 34 (04): : 276 - 277
  • [49] ICU sedation with haloperidol-propofol infusion versus midazolam-propofol infusion after coronary artery bypass graft surgery: A prospective, double-blind randomized study
    Etezadi, Farhad
    Najafi, Atabak
    Yarandi, Kourosh Karimi
    Moharari, Reza Shariat
    Khajavi, Mohammad Reza
    [J]. ANNALS OF CARDIAC ANAESTHESIA, 2012, 15 (03) : 185 - 189
  • [50] Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study
    Berk, M
    Ichim, C
    Brook, S
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (02) : 87 - 92